Micron's forecast sets the stage for stratospheric increase in earnings expectations

It's worth putting Micron's $19.15 forecast for May-quarter adjusted earnings per share into perspective, and one way to do ...

Micron is merely in the early innings of the AI boom, according to this fund manager

Investors may be worried about the sustainability of Micron's spectacular growth, but one fund manager says the company is ...

Sandisk and other memory stocks are falling in sympathy with Micron

The reaction to Micron's earnings report is rippling across the memory and storage sector in Wednesday's late trading. Micron ...

Costco Recalls Certain Sell By Dates of Meatloaf With Mashed Yukon Potatoes and Glaze Due to a Supplier's Salmonella-Related Recall

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Micron Technology, Inc. Reports Results for the Second Quarter of Fiscal 2026

BOISE, Idaho, March 18, 2026 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU) today announced results for its second quarter of fiscal 2026, which ended February 26, 2026.

The bar keeps moving higher for Micron, and that may be why the stock is down

Micron's blockbuster earnings report wasn't enough to lift the stock, which is off 3% in the extended session following the ...

Powell kicks the can down the road

Faced with tough questions about the costs to the U.S. economy from the conflict with Iran, Federal Reserve Chair Jerome ...

PC and smartphone demand is 'pretty strong' even as Micron ramps its AI business

AI-driven demand for memory has taken priority over consumer electronics. But Micron CEO Sanjay Mehrotra said that demand is ...

Independent Bank to Acquire HCB Financial in $70.2M Cash-and-Stock Deal

Independent Bank will acquire HCB Financial, the parent company of Highpoint Community Bank, for $70.2 million in cash and stock.

ADR Ratio Change

Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of rare diseases with unmet medical needs, today ...

Micron executives are devoting a lot of time to this buzzword

One buzzword — technically an acronym — stole the show on Micron's earnings call. Analysts and executives focused on SCAs, or ...

The Iran conflict might take as long as the 2022 ‘oil shock’ to blow over: TS Lombard

Returning to business as usual in the global oil market might now take months — not weeks — to achieve, according to TS ...